黄仪有博士 研究员 博士/硕士生导师
邮箱:742646380@qq.com
1.教育背景及工作经历
2021. 09 – 海南大学药学院,研究员
2020. 09 – 2021. 08 中山大学药学院,特聘副研究员
2018. 09 – 2020. 08 中山大学药学院,博士后
2015. 09 – 2018. 06 中山大学药学院,药物化学博士
2011. 09 – 2014. 06 中山大学药学院,药物化学硕士
2007. 09 – 2011. 06 南方医科大学药学院,药学学士
2.科研情况
利用X射线晶体学等结构生物学技术手段,解析药物靶标的三维结构,并以靶标为中心开展药物设计和药物化学等药学研究,特别是围绕磷酸二酯酶(PDEs)及其选择性抑制剂的开发等进行相关研究。主持国家自然科学基金面上项目、国家自然科学基金青年基金、海南省自然科学基金面上项目等6项基金,并在国内外重要学术期刊如Proc Natl Acad Sci USA、JMed Chem、Acta Pharm Sin B、Org Lett等发表SCI论文30余篇,其中(并列)一作/(共同)通讯论文有18篇,授权发明专利4项。
3.研究领域
结构生物学及基于靶标结构的药物设计
4.代表性项目
1)国家自然科学基金面上项目,2023-2026,主持
2)国家自然科学基金青年基金,2021 – 2023,主持
3)海南省自然科学基金面上项目,2022-2024,主持
4)海南大学科研启动经费,2021 – 2026,主持
5)中国博士后科学基金面上资助,2019 – 2020,主持
6)中山大学高校基本科研业务费青年教师培育项目,2018 – 2021,主持
5.代表性成果
1)Deyan Wu#, Xuehua Zheng#, Runduo Liu, Zhe Li, Zan Jiang, Qian Zhou, Yue Huang, Xu-Nian Wu, Chen Zhang,Yi-You Huang*, Hai-Bin Luo*. Free energy perturbation (FEP)-guided scaffold hopping.Acta Pharm. Sin. B.2022,12: 1351-1362.
2)Yuncong Yang#, Sirui Zhang#, Qian Zhou#, Chen Zhang, Yuqi Gao, Hao Wang, Zhe Li, Deyan Wu, Yinuo Wu,Yi-You Huang*, Lei Guo*, Hai-Bin Luo*. Discovery of Highly Selective and Orally Available Benzimidazole-based Phosphodiesterase 10Inhibitors with Improved Solubility and Pharmacokinetic Properties for Treatment of Pulmonary Arterial Hypertension.Acta Pharm. Sin. B.2020,10:2339-2347.
3)Haobai Liu#, Quan Wang#, Yue Huang#, Jinhui Deng, Xi Xie , Jiaqi Zhu , Yijun Yuan , Yue-Ming He,Yi-You Huang*, Hai-Bin Luo*, Xixin He*. Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases.Eur. J. Med. Chem.2022,242:114631.
4)Feng Zhou#, Yue Huang#, Lu Liu#, Zhendong Song, Ke-Qiang Hou, Yifan Yang, Hai-Bin Luo,Yi-You Huang*, Xiao-Feng Xiong*. Structure-based optimization of Toddacoumalone as highly potent and selective PDE4 inhibitors with anti-inflammatory effects.Biochem. Pharmacol.2022,202:115123.
5)Yi-You Huang#, Jinhui Deng#, Yi-Jing Tian#, Jinhao Liang, Xi Xie, Yue Huang, Jiaqi Zhu, Ziran Zhu, Qian Zhou, Xixin He*, Hai-Bin Luo*.Mangostanin Derivatives as Novel and Orally Active PDE4 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis with Improved Safety.J. Med. Chem.2021.64, 13736-13751.
6)Yi-You Huang#,Yan-Fa Yu#, Chen Zhang#, Yiping Chen, Qian Zhou, Zhuoming Li, Sihang Zhou, Zhe Li, Lei Guo, Deyan Wu*, Yinuo Wu*, Hai-Bin Luo*. Validation of Phosphodiesterase-10as a Novel Target for Pulmonary Arterial Hypertension via Highly Selective and Subnanomolar Inhibitors.J. Med. Chem.2019,62: 3707-3721.
7)Zhendong Song#,Yi-You Huang#, Ke-Qiang Hou#, Lu Liu, Feng Zhou, Yue Huang, Guohui Wan, Hai-Bin Luo*, Xiao-Feng Xiong*. Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis.J. Med. Chem.2022,65: 4238-4254.
8)Jinhao Liang#,Yi-You Huang#,Qian Zhou#, Yuqi Gao, Zhe Li, Deyan Wu, Si Yu, Lei Guo, Zhen Chen, Ling Huang, Steven H. Liang, Xixin He*, Ruibo Wu*, Hai-Bin Luo*. Discovery and Optimization of α-Mangostin Derivatives as Novel PDE4Inhibitors for the Treatment of Vascular Dementia.J. Med. Chem.2020,63: 3370-3380.
9)Zhe Li#,Yi-You Huang#, Yinuo Wu, Jingyi Chen, Deyan Wu, Chang-Guo Zhan*, Hai-Bin Luo*. Absolute Binding Free Energy Calculation and Design of a Subnanomolar Inhibitor of Phosphodiesterase-10.J. Med. Chem.2019,62: 2099-2111.
10)Zhe Li#, Xin Li#,Yi-You Huang#, Yaoxing Wu, Runduo Liu, Lingli Zhou, Yuxi Lin, Deyan Wu, Lei Zhang,Hao Liu, Ximing Xu, Kunqian Yu, Yuxia Zhang, Jun Cui*, Chang-Guo Zhan*, Xin Wang*, Hai-Bin Luo*. Identify Potent SARS-CoV-2 Main Protease Inhibitors via Accelerated Free Energy Perturbation-based Virtual Screening of Existing Drugs.Proc. Natl. Acad. Sci. USA.2020, 117: 27381-27387.
11)Yi-You Huang#, Xin Liu#, Deyan Wu, Guihua Tang, Zengwei Lai, Xuehua Zheng*, Sheng Yin*, Hai-Bin Luo*. The Discovery, Complex Crystal Structure, and Recognition Mechanism of a Novel Natural PDE4Inhibitor from Selaginella pulvinata.Biochem. Pharmacol.2017,130: 51-59.
12)Yi-You Huang, Zhe Li, Yinghong Cai, Lingjun Feng, Yinuo Wu, Xingshu Li, Hai-bin Luo*. The Molecular Basis for the Selectivity of Tadalafil Toward Phosphodiesterase 5 and 6: a Modeling Study.J. Chem. Inf. Model.2013,53: 3044-3053.
13)Yan-Fa Yu#, Chen Zhang#,Yi-You Huang#, Sirui Zhang, Qian Zhou, Xiangmin Li, Zengwei Lai, Zhe Li, Yuqi Gao, Yinuo Wu, Lei Guo*, Deyan Wu*, Hai-Bin Luo. Discovery and Optimization of Chromone Derivatives as Novel Selective Phosphodiesterase 10Inhibitors.ACS Chem. Neurosci.2020,11: 1058-1071.
14)Xiaoxia Qiu#,Yiyou Huang#,Deyan Wu, Fei Mao, Jin Zhu, Wenzhong Yan*, Hai-bin Luo*, Jian Li*. Discovery of Novel Purine Nucleoside Derivatives as Phosphodiesterase 2(PDE2) Inhibitors: Structure-based Virtual Screening, Optimization and Biological Evaluation.Bioorgan. Med. Chem.2018,26: 119-133.
15)Ting Yao#,Yiyou Huang#, Meng Zhang, Yujuan Chen, Hairun Pei, Jianyou Shi*, Huanchen Wang*, Yousheng Wang*, Hengming Ke*. Crystal Structures of Candida Albicans Phosphodiesterase 2and Implications for Its Biological Functions.Biochemistry,2018,57: 6070-6077.
16)Tingting Lin#,Yiyou Huang#,Guihua Tang, Zhongbin Cheng, Xin Liu, Hai-bin Luo*, Sheng Yin*. Prenylated Coumarins: Natural Phosphodiesterase-4Inhibitors from Toddalia Asiatica.J. Nat. Prod.2014,77: 955-962.
17)Yena Liu#,Yiyou Huang#, Jingmei Bao, Yinghong Cai, Yanqiong Guo, Shaonan Liu, Hai-bin Luo*, Sheng Yin*. Natural Phosphodiesterase-4(PDE4) Inhibitors from Crotalaria Ferruginea.Fitoterapia, 2014,94: 177–182.
18)Jiasheng Zhong#,Yiyou Huang#, Wenjing Ding, Xiaofang Wu, Jinzhi Wan*, Hai-bin Luo*. Chemical Constituents of Aloe Barbadensis Miller and Their Inhibitory Effects on Phosphodiesterase-4D.Fitoterapia,2013,91: 159-165.
欢迎有药学、生物学、化学等相关学科背景的同学报考本课题组的博士/硕士研究生。